QTTB
Q32 Bio Inc
NASDAQ: QTTB · HEALTHCARE · BIOTECHNOLOGY
$5.18
+14.85% today
Updated 2026-06-04
Market cap
$218.23M
P/E ratio
4.28
P/S ratio
4.06x
EPS (TTM)
$3.01
Dividend yield
—
52W range
$1 – $15
Volume
0.8M
Q32 Bio Inc (QTTB) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.18
12-Month target
$7.26
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $-0.0B | $0.0B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 4.28x (capped 25x) · Margin: 61.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.